Ignite Creation Date:
2025-12-24 @ 3:19 PM
Ignite Modification Date:
2026-02-20 @ 6:33 PM
Study NCT ID:
NCT05422092
Status:
UNKNOWN
Last Update Posted:
2022-09-21
First Post:
2022-06-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
21YXYJ0111
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None